PTGX (Protagonist Therapeutics, Inc.) Net Profit
Stiff competition with immunology leaders creates serious risks for Protagonist Therapeutics (PTGX), however, the active development of oral peptides for intestinal therapy offsets these threats. The company's actual profit clearly demonstrates the outcome of this struggle, where the 0.08 mark indicates the current yield level. Meanwhile, partnerships with industry behemoths and a diversified drug portfolio reliably protect the biotech's capitalization.
Analytical breakdowns and data insights for company Protagonist (PTGX)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Protagonist Therapeutics|PTGX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Protagonist Therapeutics, Inc.|PTGX - Company Total Debt|Debts to Book Capitalization Protagonist Corp|PTGX - Company Long-Term Debt|Company Short-Term Indebtedness Protagonist Therapeutics|Immediate Liquidity protagonist-inc.com
- net income and valuation multiples indicators:
Summary company analysis:Protagonist Therapeutics
The selection of promising issuers is based on an analysis of fundamental multiples, where cash flow dynamics determine business viability. By analyzing the company's actual profit, an investor identifies hidden capital activity during periods of stagnation, which is critical for the biotech firm Protagonist Therapeutics (PTGX) due to high cash burn and dependence on payments from J&J amidst the risk of clinical trial failure.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|IMVT (Immunovant Inc) - Final Profit|Net Profit KNSA (Kiniksa Pharmaceuticals Ltd)|Net Financial Result Grifols Biemat (GRFS)|ADPT - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|PHAR - Company Net Income|Profit After Tax NKTR|Upstream Bio Inc (UPB) - Company Net Income|zenasbio.com - Final Profit|Company Net Income Immunome|Company Net Income Gossamer Bio Inc GOSS|Net Income KALV (KalVista Pharmaceuticals Inc)|Profit After Payment of Taxes SEPN|Net Profit PVLA (Pieris Pharmaceuticals)|Net Profit savarapharma.com SVRA|Rigel Pharmaceuticals, Inc. - Net Profit|Annual Net Income AnaptysBio Inc (ANAB)|Astria Pharma (ATXS) - Company Net Income|Company Net Income enGene Corp (ENGN)|Company Net Income RAPT Therapeutics, Inc.|Company Profit JBIO (Aerovate)|Net Profit ACRS|Net Financial Result Kyverna Therapeutics Inc.|Company Net Income Tiziana Life Sciences PLC TLSA|Net Financial Result Cabaletta Bio Inc (CABA)|VTYX: Net Income|theratech.com - Profit After Payment of Taxes|AVTX (Avalo Therapeutics) - Net Income|Eledon Pharmaceuticals Inc. - Final Profit|Net Income AGEN|CLYM (Climb Bio, Inc) - Profit After Payment of Taxes|Net Profit ZURA|ATYR (atyrpharma.com) - Final Profit|Net Profit ADAG (Adagene Inc.)|ImageneBio (IMA) - Company Net Income|STTK - Company Net Income|Final Profit EQ (Equillium, Inc.)|CNTB: Net Profit|Immunic (IMUX) - Net Profit|Company Net Income Atara Biotherapeutics, Inc.|InflaRx GmbH - Profit After Tax|Net Profit XFOR|ACET - Company Net Income|Celularity - Net Income|Net Profit inmunebio.com INMB|BRNS: Net Income|Kezar Life Sciences Inc. - Profit After Payment of Taxes|SABS: Net Profit|AKTX - Net Financial Result|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Net Income Q32 Bio Corp (QTTB)|Company Net Income GeoVax (GOVX)|Net Financial Result Edesa Biotech Inc|Company Net Income iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Profit After Tax|XTLB: Net Income|Bolt Biotherapeutics - Profit After Payment of Taxes|HCWB: Net Profit|Annual Net Income Aptevo Therapeutics Inc. APVO|Net Income AIM|Company Profit ADTX (Aditxt Corp)|Company Net Income GRI Bio, Inc. (GRI)|XRTX: Profit After Tax|Net Profit HIND (Vyome Holdings)|Final Profit REVB|Indaptus - Net Profit|SCNI - Net Profit|calcimedica.com (CALI) - Company Net Income|Affimed N.V. - Final Profit|Company Net Income Allakos Inc|Net Income HOOKIPA (HOOK)|Net Profit IGMS|Net Profit iTeos Pharma (ITOS)|Ocean Biomedical, Inc. - Net Income|Final Profit TCBP|Third Harmonic Bio, Inc. - Net Profit